2 employees
Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control.
2020
$133K
from 2 investors over 2 rounds
Nyctea Technologies raised $133K on September 27, 2022
Investors: Chalmers Ventures
Nyctea Technologies raised $5.7K on October 28, 2020